BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16308474)

  • 1. p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt.
    Zalata KR; Nasif WA; Ming SC; Lotfy M; Nada NA; El-Hak NG; Leech SH
    Cell Oncol; 2005; 27(4):245-53. PubMed ID: 16308474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between multi-gene proteins in colorectal carcinoma complicated with chronic schistosomiasis: an immunohistochemical study by using tissue microarray techniques].
    Yang DH; Qiu CM; Sun WW; Gu MM; He PF; Xu YY
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Aug; 26(4):405-9. PubMed ID: 25434139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products.
    Langlois NE; Lamb J; Eremin O; Heys SD
    J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.
    Zalata KR; Elshal MF; Foda AA; Shoma A
    Tumour Biol; 2015 Aug; 36(8):6579-84. PubMed ID: 25840688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer.
    Popescu RA; Lohri A; de Kant E; Thiede C; Reuter J; Herrmann R; Rochlitz CF
    Eur J Cancer; 1998 Jul; 34(8):1268-73. PubMed ID: 9849490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
    Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
    Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
    Kikuchi Y; Dinjens WN; Bosman FT
    Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis.
    Wang DG; Liu WH; Johnston CF; Sloan JM; Buchanan KD
    Am J Pathol; 1998 Jun; 152(6):1407-13. PubMed ID: 9626044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma.
    Palazzo JP; Kafka NJ; Grasso L; Chakrani F; Hanau C; Cuesta KH; Mercer WE
    Hum Pathol; 1997 Oct; 28(10):1189-95. PubMed ID: 9343326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2, p53 and c-myc expression in juvenile dermatomyositis.
    Falcini F; Calzolari A; Generini S; Pignone A; Simonini G; Zulian F; Matucci-Cerinic M
    Clin Exp Rheumatol; 2000; 18(5):643-6. PubMed ID: 11072611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
    Gurzu S; Jung J; Mezei T; Pávai Z
    Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and proliferative activity of non-Hodgkin's lymphomas: comparison with expression of bcl-2, p53 and c-myc proteins.
    Takano Y; Saegusa M; Ikenaga M; Okayasu I
    Pathol Int; 1997; 47(2-3):90-4. PubMed ID: 9088026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinicopathological significance of
    Yang XG; Yang JW; Zhao PJ; Cheng W; Shi HB; Zhang B; Fu QC; Li Y
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Apr; 33(2):148-153. PubMed ID: 34008361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation, bcl-2, c-myc, p53 and apoptosis as indicators of different aggressiveness in small lymphocytic lymphoma (SLL).
    Palestro G; Ponti R; Chiusa L; Chiarle R; Geuna M; Novero D; Freilone R; Pich A
    Eur J Haematol; 1997 Sep; 59(3):148-54. PubMed ID: 9310122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
    Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis dysregulation in human gastric carcinomas: relationship to anti- and pro-apoptotic protein expression.
    Nasif WA; El-Emshaty HM; Lotfy M; Zalata K; El-Hak NG
    Asian Pac J Cancer Prev; 2007; 8(1):45-50. PubMed ID: 17477770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
    Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
    Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
    Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
    Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of relation of AKAP12 with p53 and Bcl-2 in colorectal carcinoma.
    Suren D; Yildirim M; Alikanoglu AS; Kaya V; Yildiz M; Dilli UD; Sezer C
    Asian Pac J Cancer Prev; 2014; 15(8):3415-8. PubMed ID: 24870731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.